Amit Vohra, PhD, MBA
About Amit Vohra, PhD, MBA
Amit Vohra: President and Chief Executive Officer
Amit Vohra serves as the President and Chief Executive Officer, bringing extensive experience and strategic leadership to his role. His background encompasses several executive positions and notable contributions in advancing medical technologies and biotechnology companies.
Amit Vohra's Educational Background and Expertise
Amit Vohra holds a Doctorate in Mechanical Engineering from the University of Florida, showcasing his strong technical foundation. He also earned an MBA from Duke University's Fuqua School of Business, where he was recognized as a Fuqua Scholar. This combination of technical expertise and business acumen allows him to effectively lead and innovate in the biotechnology field.
Amit Vohra's Role in Navya Biomedical Technologies
As a co-founder of Navya Biomedical Technologies, Amit Vohra has been pivotal in utilizing proprietary polyhydroxy fullerenes for non-invasive imaging and the destruction of solid tumors. His contributions have helped position the company as an innovator in the biotechnology sector.
Amit Vohra's Leadership at Convergent Life Sciences
In his previous role as CEO/President of Convergent Life Sciences, Amit Vohra led the company to achieve FDA clearance for an MRI-US fusion product designed for targeted laser ablation of soft tissue cancer. This milestone was accomplished within just 18 months of the company's formation, demonstrating his effective leadership and strategic vision.
Amit Vohra's Contributions at Eigen
During his tenure as VP of Strategy and Operations at Eigen, Amit Vohra led the development and successful commercialization of two class II medical devices in the prostate biopsy space. His strategic oversight contributed significantly to the company's growth and technological advancements.
Amit Vohra's Advisory Roles and Consultancy
Amit Vohra serves as a board member at Navaux and provides advisory support to companies such as Fanisko, Triocula, and UnityDx. Additionally, he is a Partner in Advanced Biopharma Consulting, where he offers strategic business development and commercialization services within the life sciences sector.